Corcept Therapeutics (CORT) Deferred Taxes (2017 - 2025)
Historic Deferred Taxes for Corcept Therapeutics (CORT) over the last 9 years, with Q3 2025 value amounting to $9.1 million.
- Corcept Therapeutics' Deferred Taxes rose 15993.29% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.2 million, marking a year-over-year increase of 3447.57%. This contributed to the annual value of -$40.2 million for FY2024, which is 3627.3% down from last year.
- Latest data reveals that Corcept Therapeutics reported Deferred Taxes of $9.1 million as of Q3 2025, which was up 15993.29% from -$17.8 million recorded in Q2 2025.
- Corcept Therapeutics' Deferred Taxes' 5-year high stood at $9.1 million during Q3 2025, with a 5-year trough of -$17.8 million in Q2 2025.
- In the last 5 years, Corcept Therapeutics' Deferred Taxes had a median value of -$7.2 million in 2024 and averaged -$6.4 million.
- Its Deferred Taxes has fluctuated over the past 5 years, first plummeted by 67879.97% in 2022, then skyrocketed by 15993.29% in 2025.
- Quarter analysis of 5 years shows Corcept Therapeutics' Deferred Taxes stood at $2.3 million in 2021, then crashed by 294.3% to -$4.5 million in 2022, then increased by 17.8% to -$3.7 million in 2023, then decreased by 5.07% to -$3.9 million in 2024, then surged by 336.24% to $9.1 million in 2025.
- Its Deferred Taxes stands at $9.1 million for Q3 2025, versus -$17.8 million for Q2 2025 and -$13.7 million for Q1 2025.